NDC product
Hydromorphone Hydrochloride
NDC 0703-0018 · Teva Parenteral Medicines, Inc.
Key facts
| Product NDC | 0703-0018 |
|---|---|
| Proprietary name | Hydromorphone Hydrochloride |
| Nonproprietary name | HYDROMORPHONE HYDROCHLORIDE |
| Substances | HYDROMORPHONE HYDROCHLORIDE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| Labeler | Teva Parenteral Medicines, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA078591 |
| DEA schedule | CII |
| Pharmacologic classes | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| Marketing start | Jan 18, 2011 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: